Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medium-chain triacylglycerol oil (MCT oil) is a mixture of saturated fatty acid esters of glycerol containing fatty acids with carbon chain lengths typically between 6 and 12. The main components are caprylic acid (C8) and capric acid (C10) triglycerides. It is derived primarily from coconut oil or palm kernel oil through fractionation and esterification processes[1][2][4][6]. MCTs are rapidly absorbed in the gastrointestinal tract and transported directly to the liver via the portal vein for quick energy production rather than storage as fat. This unique metabolic pathway makes them useful for patients with fat malabsorption syndromes or those requiring parenteral nutrition[3][7]. In addition to their use as a dietary supplement for sustained energy and cognitive support[1], they serve as pharmaceutical excipients—solubilizers/carriers in oral or topical drug formulations due to their excellent stability and low viscosity[1][8]. There is no evidence of mutagenicity or reproductive toxicity based on available studies; they are not classified as hazardous substances under transport regulations[5]. They do not contain essential fatty acids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on medium-chain triacylglycerol oil.